Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemia
Open Access
- 23 April 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
Abstract
Juvenile myelomonocytic leukemia (JMML) is a myeloproliferative disorder that predominantly affects infants and young children. Hematopoietic stem cell transplantation (HSCT) is standard of care, but post-HSCT relapse is common, highlighting the need for innovative therapies. While adoptive immunotherapy with chimeric antigen receptor (CAR) T cells has improved outcomes for patients with advanced lymphoid malignancies, it has not been comprehensively evaluated in JMML. In the present study, we use bulk and single-cell RNA sequencing, mass spectrometry, and flow cytometry to identify overexpression of CLL-1 (encoded by CLEC12A) on the cell surface of cells from patients with JMML. We develop immunotherapy with CLL-1 CAR T cells (CLL1CART) for preclinical testing and report in vitro and in vivo anti-leukemia activity. Notably, CLL1CART reduce the number of leukemic stem cells and serial transplantability in vivo. These preclinical data support the development and clinical investigation of CLL-1-targeting immunotherapy in children with relapsed/refractory JMML.Keywords
Funding Information
- Cookies for Kids' Cancer, Leukemia Lymphoma Society, Shaw Foundation, California Cancer League
- Deutsche Krebshilfe
- Else Kröner-Fresenius-Stiftung
- U.S. Department of Health & Human Services | National Institutes of Health
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- Alex's Lemonade Stand Foundation for Childhood Cancer
This publication has 82 references indexed in Scilit:
- Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cellsBlood, 2014
- Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cellsNature, 2011
- Acute myeloid leukemia stem cells: seek and destroyExpert Review of Hematology, 2009
- Activated T–cell-mediated Immunotherapy With a Chimeric Receptor Against CD38 in B-cell Non-Hodgkin LymphomaJournal of Immunotherapy, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- The novel AML stem cell–associated antigen CLL-1 aids in discrimination between normal and leukemic stem cellsBlood, 2007
- Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trialBlood, 2005
- C-Type Lectin-Like Molecule-1Cancer Research, 2004
- Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID miceBlood, 1996
- Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors.1991